Shop
-
Tafinlar (Dabrafenib) – NSCLC | DengYue Medicine
-
Calquence (Acalabrutinib) – CLL | DengYueMed
-
Orelabrutinib – Chronic Lymphocytic Leukemia | DengYueMed
-
Venclexta (Venetoclax) – CLL | DengYueMed
-
Brukinsa (Zanubrutinib) – CLL | DengYueMed
-
Treanda (Bendamustine Hydrochloride) – CLL | DengYueMed
-
Imfinzi (Durvalumab) – NSCLC | DengYue Medicine
-
Camrelizumab – NSCLC | HongKong DengYue Medicine
-
Esperoct (Turoctocog Alfa Pegol) – Hemophilia A | DengYueMed
-
NovoSeven (Recombinant Coagulation Factor VIIa) – Hemophilia A | DengYue
-
Kovaltry (Recombinant Factor VIII) – Hemophilia A | DengYue
-
Vizimpro (Dacomitinib) – NSCLC | HongKong DengYue Medicine
-
Keytruda (Pembrolizumab) – NSCLC | HongKong DengYue Medicine
-
Ninlaro (Ixazomib) – Multiple Myeloma | HongKong DengYue Medicine
-
Shaite (Aponermin) – Multiple Myeloma | HongKong DengYue Medicine
-
Darzalex (Daratumumab) – Multiple Myeloma | HongKong DengYue Medicine
